Case File
efta-efta01166570DOJ Data Set 9OtherFrom: Jeffrey Epstein <[email protected]>
Date
Unknown
Source
DOJ Data Set 9
Reference
efta-efta01166570
Pages
4
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From: Jeffrey Epstein <[email protected]>
To: Tazia Smith <I
Subject: Re: Citi K fixed-to-float... [C]
Date: Mon, 03 Feb 2014 19:19:25 +0000
Inline-Images: unnamed; unnamed(1); unnamed(2); unnamed(3)
2milliojn
On Mon, Feb 3, 2014 at 2:14 PM, Tazia Smith <
> wrote:
Classification: Confidential
Jeffrey -
Will be back with complete thoughts on all of the below, but given nice pullback today, some
highlights (potentially timely entry points) are popping up, for one:
Consider buying some of the Citi K fixed to floats today.
They went ex-div today (50c) and are trading —$25.25 (down 45c). As you know, they're fixed at
6.875% and float in '23 at 3moL +413bps. One quarterly coupon and you've recouped the moderate
premium to par
C 6 78 12/31/49 $
12S.2So
K25.230 /25.250 '+
3x25
EXCI.
At 13:57
Vol 177,757
C 25.300P F 25.320N L 25.2006 Val 4.487M
EP045024 Pfd
10/28/2013
1D
9, Save As
99 Actions
Line
1Y
SY
Max
Daily •
It Track
Annotate
02/03/2014
3D
1M
6M
YID
Last Price
Ta
ID Compare
Mov. .A
MOM
Line Chart
MEIN
'4 Event
O
Volume
secuntotxty
NewS O, Zoom
1
• Last Price
25.250
I High on 01/22/14 25.890
-9- Average
25:243
1. Low on 10/30/B 24.870
25.800
25.600
25.400
25.230
L.J.LVV
25.000
24.800
9.•• Volume
0.178M
L •
SMAVG (15) 1.077M
Oct 31
Nov 15
Nov 29
2013
Dec 16
Dec 31
Jan 15
Jan 31
2014
5M
EFTA01166570
Tazia Smith
Director I Key Client Partners - US
Deutsche Bank Securities Inc
e✓fcron
From:
Jeffrey Epstein leevacSg
ti
mail.com>
To.
02/02/2014 08:59 PM
Subject:
percentages get a read from your team
EFTA01166571
Equity
Energy
Equity
Financials
Equity
Bristol Myers
$
2.50
Pfizer
$
2.50
Merck
$
2.50
Valeant
$
1.50
Actavis
$
1.50
Gilead
$
1.50
Mylan
$
1.00
Endo Health
$
1.00
HCA
$
0.50
Rite Aid
$
0.50
Sub Total
$ 15.00
Energy Renaisance Theme
$ 15.00
Sub Total
Bank of America
S
3.00
Fixed-to-Float Preforreds• (ODI Eligible)
JPM 6.75%. BBB. callable 2024
$
3.00
Cdi - K 6.875% BB+. nibble 2023
$
3.00
Morgan Stanley - F 6.875%. BB+, callable 2024
$
2.00
Ally - B 0.50%. B, callable 2016
$
1.00
Sub Total
$
9.00
Fixed Income
Europe
Equity Recovery
Consumer
Carrefour
S
1.50
Financial
Intesa Sanoaolo
S
1.50
Auto
Volkswagen
S
1.50
Advertising
JC Oecaux
S
1.50
Staffing
Adecco
S
1.50
Insurance
Grupo Catalana
S
0.50
Healthcare
Roche Holdings
S
1.00
Energy
Total
S
1.00
Sub Total
S 10.00
Agency Interest Only Mortgages 5% Coupon
Agency Interest Only Mortgages 4.5% Coupon
Sub Total
Total
$
5.00
$
5.00
$ 10.00
$ 52.00
Eurostoxx Barrier Note
$ 10.30
Total
$ 20.00
Japan
Equity
Financials
Sumitomo
$
0.50
Insurance
Mitsui Fudosan
$
0.50
Oaiichi Life
$
0.50
Consumer
Seven and I
$
0.50
Unicharm
$
0.50
Exporters
Sumitomo Electric
$
0.50
Toyota
$
0.50
Japan Tobacco
$
0.50
Hitachi
$
0.50
Advertising
Oentsu
$
0.50
Sub Total
$
5.00
TOPIX Delta One Note
$
7.00
Foreign Exchange
Long USD / Short Yen ($5 hedge. S8 spec)
S 13.00
Total
$ 20.00
Alternatives
Credit
Watford Re:
$
8.00
Total
$
8.00
EFTA01166572
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to jeex
[email protected], and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
This communication may contain confidential and/or privileged information.
If you are not the intended recipient (or have received this communication
in error) please notify the sender immediately and destroy this
communication. Any unauthorized copying, disclosure or distribution of the
material in this communication is strictly forbidden.
Deutsche Bank does not render legal or tax advice, and the information
contained in this communication should not be regarded as such.
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to jeevacation®gmail.com, and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
EFTA01166573
Technical Artifacts (2)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Email
[email protected]Email
[email protected]Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.